FDA to Review Arexvy for 18 to 49-Year-Olds at Inc
分类： Haymarket Media
Moderna 的新型流感疫苗在老年人中显示出强劲的效果
Moderna’s New Flu Shot Shows Strong Results in Old
ACIP 建议将 Enflonsia 用于预防婴儿 RSV
ACIP Recommends Enflonsia for RSV Prevention in In
一年两次的 HIV-1 PrEP Yeztugo 获得 FDA 批准
Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval
父母似乎接受儿童在 9 岁或 10 岁时接种 HPV 疫苗
Parents Appear Receptive to Children Receiving HPV
RSV 住院与 COVID-19 住院的心血管事件几率上升
Odds of Cardiovascular Events Up for RSV Hospitali
世界部分地区出现新的 COVID-19 变种
Parts of the World Seeing New COVID-19 Variant 发布日
美国面临 2000 年以来最大规模的麻疹疫情
US Faces Largest Measles Outbreak Since 2000 发布日期4
静脉注射免疫球蛋白可改善脊髓灰质炎后患者的身体机能
Intravenous Immunoglobulin Improves Physical Perfo
疫苗接种不会影响长期的COVID神经症状
Vaccination Does Not Impact Long COVID Neurologica
2023年至2024年，十分之八的婴儿接受了呼吸道合胞病毒保护
Eight in 10 Infants Received RSV Protection in the
2024新药和生物制品批准
2024 Novel Drug and Biological Product Approvals 戴
针对金黄色葡萄球菌的候选疫苗获得快速通道地位
Vaccine Candidate Against Staphylococcus aureus Ge
Clesrovimab在婴儿RSV预防中的应用
Clesrovimab Under Review for RSV Prevention in Inf
Xalnesiran联合治疗对乙型肝炎患者有希望
Combo Treatment With Xalnesiran Shows Promise in P
生殖器单纯疱疹病毒感染的全球发病率和流行率高
Global Incidence, Prevalence High for Genital Herp
研究调查了母亲RSV疫苗Nirsevimab在婴儿中的成本效益
Studies Examine Cost-Effectiveness of Maternal RSV